Clinical Trial Update: Evaluation of the Efficacy and Safety of Adebrelimab Combined With SOX as Adjuvant Therapy for IIIB and IIIC Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Adebrelimab in combination with the SOX chemotherapy regimen as adjuvant therapy for IIIB/IIIC gastric cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cance | Phase 2 | Status: NOT_YET_RECRUITING